Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00314431
Other study ID # BG99547
Secondary ID R01HS007928
Status Completed
Phase Phase 3
First received April 11, 2006
Last updated November 1, 2017
Start date May 1996
Est. completion date August 2000

Study information

Verified date April 2006
Source Wake Forest University Health Sciences
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Based on success with telephone follow up for other groups of medically fragile infants, we designed an innovative model of post-hospital comprehensive and coordinated follow-up for infants with chronic lung disease. In this model, which we refer to as community-based follow-up, medical management was coordinated by a nurse specialist, through frequent telephone contacts with the infants' primary caregiver. This model of follow up care was compared, in a randomized trial, with the more traditional model - multidisciplinary medical center-based care. We hypothesized that community-based care would lead to health and developmental outcomes similar to those observed with center-based care.


Description:

METHODS Study design A randomized equivalence trial was designed to compare community-based follow up with medical-center based follow up. The primary outcome was assessed at one year adjusted age.

Study participants Infants were recruited in five neonatal intensive care units in northwest North CArolina. These were the only sites providing neonatal intensive care in a twenty-county region in northwest North Carolina. Infants were born between March 1996 and September 1999. Infants were eligible for the study if they were born before 33 weeks gestational age, required supplemental oxygen at 36 weeks gestational age, and were discharged home after neonatal intensive care. Neonates who had major congenital anomalies and/ or had tracheostomy tubes were excluded. Also excluded were families in which the mother did not speak English, because the intervention depended on verbal communication with the nurse specialist, and families who lived more than 150 miles from our clinic because such families typically are referred to regional neonatal center closer to their home.

Randomization A randomization list was prepared by a biostatistician who was not involved in data collection or clinical care of the infants. Lists of randomization assignments, which were kept in a sealed envelope in a locked drawer, were prepared for each of the five sites at which participants were recruited. Randomization assignments were made in blocks sizes of two and four. Once a study participant arrived home from the neonatal intensive care unit, a research assistant uncovered the next assignment on the randomization list, which was kept in a sealed envelope in a locked drawer.

Intervention If the family did not have telephone service at the time of the infant's discharge, a telephone was installed at no cost to the family, within one week of the infant's discharge from the hospital. Research funds were used to reimburse all families for the cost of local phone service for the duration of the study. Families assigned to either intervention could contact the nurse specialist on a toll-free long distance line with voice mail which recorded messages when the phone was not attended.

The intervention team consisted of two neonatologists, a pediatric social worker, and a nurse specialist.

Community-based follow up Telephone contacts were made to the infants' primary caregiver by the nurse specialist twice weekly in the first month after discharge, weekly in months two through four, and monthly thereafter until the infant attained 12 months adjusted age. At each telephone contact, the nurse used a semi-structured format to inquire about the infant's health, community resources utilized by the infant, and potential stressors and sources of support for the family. She also inquired about the infant's medications and feedings. If she judged the infant would benefit from a change in medical management, additional assessments or a subspecialty referral, she discussed the proposed change with one of the two study neonatologists. If there was agreement, the recommendation was communicated to the family and the infant's primary care provider. The nurse specialist also coordinated care for the infant by communicating with home health nurses, public health nurses, early intervention specialists, physical therapists, and pediatric sub-specialists.

Medical center-based follow up For infants who were discharged home on supplemental oxygen, the nurse specialist made a home visit 1 to 2 weeks after discharge. During this visit, the nurse specialist obtained interim medical history, performed physical assessment including pulse oximetry and body weight, reviewed discharge instructions regarding medication dosage and use of durable medical equipment, and answered caregiver's questions about the infant's care. If the nurse specialist had concerns about the medical condition of the infant, she made changes to the plan of care after consultation with the study neonatologist.

All infants assigned to the center-based care group were seen in the regional, high-risk infant multidisciplinary clinic at Wake Forest University School of Medicine. The first clinic visit occurred approximately one month after their discharge. A multidisciplinary team consisting of the social worker, the nurse specialist and the neonatologist obtained detailed interim medical history (feeding, respiratory status, medication history, illnesses and health-services utilization) and performed a complete physical examination. Family stressors and resources were discussed. All infants were scheduled for visits at four, eight, and twelve months adjusted age. In addition, infants who were using supplemental oxygen were seen at an interval of 1-2 months until all of the following criteria were met: 1) their growth rate was 15-30 grams/day, 2) they were no longer using supplemental oxygen or other medications, and 3) they were no longer using a home apnea monitor. At each clinic visit, the infant and parent or guardian were seen individually by the clinic social worker, the nurse specialist for this project, and one of the two neonatologists who conferred as a group and developed a plan of care. This plan was communicated to the family by the nurse specialist.

Communication with primary care providers Within 24 hours after randomization, the principal investigator called the infants' primary care providers to inform them about the study design and that the parents have consented to participate in the study. In the case of infants randomized to community-based care, the primary care provider was given the choice of making the decisions about changes in medical care independently or jointly with the nurse specialist. A copy of a protocol for management of infants with CLD, developed by the study team was mailed to each primary care provider. After each clinic visit (for the center-based group) the primary care provider received a letter describing findings, impressions, and recommendations. Contacts with the primary care physicians of infants randomized to community-based care occurred whenever the nurse specialist believed that a change in care was indicated.

Outcomes assessed during the first year Self-administered questionnaires were used to assess psychosocial status of the family, healthcare utilization and healthcare expenses at baseline, one, four, seven and eleven months. Each time the family completed study questionnaires and when home visits were made, families were given twenty dollars as compensation. At eleven months, a research assistant conducted a home visit and assessed the home using the Caldwell HOME Inventory,27 and the parent-infant interaction using a scale developed by Holditch and Miles.28 Only results of rehospitalization rates during the first year will be presented in this paper.

Outcomes assessed at one year adjusted age All children were evaluated at one year adjusted age at a Development Evaluation Clinic dedicated solely to developmental assessments of high-risk infants. The primary outcome, the Bayley Scales of Infant Development-Second Edition (BSID-2) Mental Developmental Index (MDI)I, and two secondary outcomes - the BSID Pyschomotor Developmental Index (PDI) and the Vineland Adaptive Behavioral Scales (VABS) were assessed by child psychologists or psychology graduate students supervised by a child psychologist, who were not aware of the child's intervention group or medical history. After the testing was completed, the psychologist was informed of the infant's gestational age at birth, so that the BSID scores could be corrected for the degree of prematurity. The BSID MDI is a widely used and validated developmental assessment tool to measure cognitive development in the first two years of life. The BSID PDI measures fine and gross motor development.29 The population mean for both the scores is 100 with a standard deviation of 15. Higher score on BSID MDI and PDI represents better cognitive and motor functioning respectively.30 When the BSID MDI/ PDI score was less than 50, then the score was extrapolated as described previously.31

The Vineland Adaptive Behavior Scales are a parent-reported measure of child adaptive development. The scale assesses four domains of adaptive development: communication, daily living skills, socialization, and motor skills. The overall Adaptive Behavior Composite (ABC) is a standard score based on the child's age, with higher scores representing better adaptive functioning. Population mean for ABC is 100 and the standard deviation is 15.32

Anthropometric measurements were performed by a neonatologist, who was aware of the infants' intervention assignment, using a pediatric scale for weight, a length board for length, and a tape measure for head circumference. Growth delay was defined as weight for length less than 5th percentile at one year adjusted age. At 1 year follow-up, a research assistant reviewed each child's clinic chart and noted whether any of the following health conditions or receipt of health-services: cerebral palsy, blindness, hearing impairment, seizure disorder, oxygen requirement, need for tracheostomy tube and ventriculo-peritoneal shunt.


Recruitment information / eligibility

Status Completed
Enrollment 150
Est. completion date August 2000
Est. primary completion date
Accepts healthy volunteers No
Gender All
Age group N/A to 483 Days
Eligibility Inclusion Criteria:

- Infants were eligible if they were born before 33 weeks gestational age, required supplemental oxygen at 36 weeks gestational age, and were discharged home after neonatal intensive care.

Exclusion Criteria:

- Neonates who had major congenital anomalies and/ or had tracheostomy tubes were excluded. Also excluded were families in which the mother did not speak English, because the intervention depended on verbal communication with the nurse specialist, and families who lived more than 150 miles from our clinic because such families typically are referred to regional neonatal center closer to their home.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Care coordination by telephone contacts with a nurse


Locations

Country Name City State
United States Wake Forest University School of Medicine Winston-Salem North Carolina

Sponsors (1)

Lead Sponsor Collaborator
Wake Forest University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Bayley Scales of Infant Development-Second Edition
Secondary Growth through one year of age
Secondary Rehospitalizations in the first year of life
Secondary Vineland Adaptive Behavioral Scales
See also
  Status Clinical Trial Phase
Terminated NCT04506619 - Safety and Efficacy Outcomes Following Previously Administered Short-Term Treatment With SHP607 in Extremely Premature Infants
Completed NCT04936477 - Ventilation-perfusion (V/Q) Ratio and Alveolar Surface Area in Preterm Infants N/A
Recruiting NCT05285345 - Implementation of a Consensus-Based Discharge Protocol for Preterm Infants With Lung Disease
Completed NCT03649932 - Enteral L Citrulline Supplementation in Preterm Infants - Safety, Efficacy and Dosing Phase 1
Terminated NCT02524249 - Early Versus Late Caffeine for ELBW Newborns N/A
Completed NCT02249143 - Duration of Continuous Positive Airway Pressure and Pulmonary Function Testing in Preterm Infants N/A
Active, not recruiting NCT01632475 - Follow-Up Study of Safety and Efficacy of Pneumostem® in Premature Infants With Bronchopulmonary Dysplasia
Completed NCT01460576 - Improving Prematurity-Related Respiratory Outcomes at Vanderbilt N/A
Completed NCT00419588 - Growth of Airways and Lung Tissues in Premature and Healthy Infants
Unknown status NCT00254176 - Cysteine Supplementation in Critically Ill Neonates Phase 2/Phase 3
Completed NCT00208039 - Pilot Trial of Surfactant Booster Prophylaxis For Ventilated Preterm Neonates N/A
Completed NCT00319956 - Trial II of Lung Protection With Azithromycin in the Preterm Infant Phase 2
Completed NCT00006401 - Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants Phase 3
Terminated NCT05030012 - Maintaining Optimal HVNI Delivery Using Automatic Titration of Oxygen in Preterm Infants N/A
Completed NCT00006058 - Study of the Pathobiology of Bronchopulmonary Dysplasia in Newborns N/A
Completed NCT00005376 - Premature Birth and Its Sequelae in Women N/A
Completed NCT00011362 - Dexamethasone Therapy in VLBW Infants at Risk of CLD Phase 3
Completed NCT00004805 - Study of the Effect of Four Methods of Cardiopulmonary Resuscitation Instruction on Psychosocial Response of Parents With Infants at Risk of Sudden Death N/A
Completed NCT05152316 - The Baby Lung Study
Recruiting NCT04821453 - NAVA vs. CMV Crossover in Severe BPD N/A